首页> 外文期刊>国际肝胆胰疾病杂志(英文版) >Expression of L amino acid transport system 1 and analysis of iodine-123-methyltyrosine tumor uptake in a pancreatic xenotransplantation model using fused high-resolution-micro-SPECT-MRI
【24h】

Expression of L amino acid transport system 1 and analysis of iodine-123-methyltyrosine tumor uptake in a pancreatic xenotransplantation model using fused high-resolution-micro-SPECT-MRI

机译:融合异种高分辨率SPECT-MRI技术在胰腺异种移植模型中L氨基酸转运系统1的表达及碘123-甲基酪氨酸肿瘤摄取的分析

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: The specificity in discriminating pancreatitis is limited in the positron emission tomography (PET) using Fluorine-18-fluorodeoxyglucose.Furthermore,PETisnot widely available compared to the single photon emission computed tomography (SPECT). Since amino acids play a minor role in metabolism of inflammatory cells, the potential of the SPECT tracer, 3-[123I]iodo-L-α-methyltyrosine (123I-IMT), for detecting pancreatic cancer was examined in xenotransplantation models of humanpancreaticcarcinomainmice. METHODS:  123I-IMT was injected to eight mice inoculated with subcutaneous or orthotopic pancreatic tumors. Fused high-resolution-micro-SPECT (Hi-SPECT) and magnetic resonance imaging were performed. The gene expression level of L amino acid transport-system 1 (LAT1) was analyzed and correlated with tumor uptake of 123I-IMT. RESULTS: A high uptake of 123I-IMT was detected in all tumor-bearing mice. The median tumor-to-background ratio (T/B) was 12.1 (2.0-13.2) for orthotopic and 8.4 (1.8-11.1) for subcutaneous xenotransplantation, respectively. Accordingly, the LAT1 expression in transplanted Colo357 cells was increased compared to non-malignant controls. CONCLUSIONS: Our mouse model could show a high 123I-IMT uptake in pancreatic cancer. Fused MRI scans facilitate precise evaluation of uptake in the specific regions of interest. Further studies are required to confirm these findings in tumors derived from other human pancreatic cancer cells. Since amino acids play a minor role in the metabolism of inflammatory cells, the potential for application of 123I-IMT to distinguish pancreatic tumor from inflammatory pancreatitis warrants further investigation.
机译:背景:区分胰腺炎的特异性在使用氟-18-氟脱氧葡萄糖的正电子发射断层扫描(PET)中受到限制。此外,与单光子发射计算机断层扫描(SPECT)相比,PET尚不广泛。由于氨基酸在炎性细胞的代谢中起次要作用,因此在人类胰腺癌小鼠异种移植模型中检查了SPECT示踪剂3- [123I]碘-L-α-甲基酪氨酸(123I-IMT)检测胰腺癌的潜力。 方法:向八只接种了皮下或原位胰腺肿瘤的小鼠注射123I-IMT。进行了融合的高分辨率微SPECT(Hi-SPECT)和磁共振成像。分析L氨基酸转运系统1(LAT1)的基因表达水平,并将其与123I-IMT的肿瘤摄取相关。 结果:在所有荷瘤小鼠中均检测到123I-IMT的高摄取。异位皮下移植的平均肿瘤与背景之比(T / B)为12.1(2.0-13.2),皮下异种移植为8.4(1.8-11.1)。因此,与非恶性对照相比,移植的Colo357细胞中LAT1表达增加。 结论:我们的小鼠模型可能显示胰腺癌中高123I-IMT摄取。融合MRI扫描有助于精确评估特定目标区域中的摄取。需要进一步的研究以证实在源自其他人胰腺癌细胞的肿瘤中的这些发现。由于氨基酸在炎性细胞的代谢中起次要作用,因此应用123I-IMT区分胰腺肿瘤与炎性胰腺炎的潜力值得进一步研究。

著录项

  • 来源
    《国际肝胆胰疾病杂志(英文版)》 |2011年第001期|30-37|共8页
  • 作者单位

    Department of Nuclear Medicine, Institute of Human Genetics, Institute for Experimental Cancer Research, Institute of Neuroradiology, and Department of General Surgery and Thoracic Surgery, University Hospital of Schleswig-Holstein, Campus Kiel, Germany;

    Department of Nuclear Medicine, Institute of Human Genetics, Institute for Experimental Cancer Research, Institute of Neuroradiology, and Department of General Surgery and Thoracic Surgery, University Hospital of Schleswig-Holstein, Campus Kiel, Germany;

    Department of Nuclear Medicine, Institute of Human Genetics, Institute for Experimental Cancer Research, Institute of Neuroradiology, and Department of General Surgery and Thoracic Surgery, University Hospital of Schleswig-Holstein, Campus Kiel, Germany;

    Department of Nuclear Medicine, Institute of Human Genetics, Institute for Experimental Cancer Research, Institute of Neuroradiology, and Department of General Surgery and Thoracic Surgery, University Hospital of Schleswig-Holstein, Campus Kiel, Germany;

    Department of Nuclear Medicine, Institute of Human Genetics, Institute for Experimental Cancer Research, Institute of Neuroradiology, and Department of General Surgery and Thoracic Surgery, University Hospital of Schleswig-Holstein, Campus Kiel, Germany;

    Department of Nuclear Medicine, Institute of Human Genetics, Institute for Experimental Cancer Research, Institute of Neuroradiology, and Department of General Surgery and Thoracic Surgery, University Hospital of Schleswig-Holstein, Campus Kiel, Germany;

    Department of Nuclear Medicine, Institute of Human Genetics, Institute for Experimental Cancer Research, Institute of Neuroradiology, and Department of General Surgery and Thoracic Surgery, University Hospital of Schleswig-Holstein, Campus Kiel, Germany;

    Department of Nuclear Medicine, Institute of Human Genetics, Institute for Experimental Cancer Research, Institute of Neuroradiology, and Department of General Surgery and Thoracic Surgery, University Hospital of Schleswig-Holstein, Campus Kiel, Germany;

    Department of Nuclear Medicine, Institute of Human Genetics, Institute for Experimental Cancer Research, Institute of Neuroradiology, and Department of General Surgery and Thoracic Surgery, University Hospital of Schleswig-Holstein, Campus Kiel, Germany;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号